Isis Pharmaceuticals has appointed Jeffrey Jones as executive vice president.
In this position, Jones will lead clinical development, preclinical development, regulatory affairs, and quality assurance and compliance at Isis, the company said.
Prior to joining Isis, Jones held various positions at Forest Laboratories, most recently chief medical officer and executive vice president. Before working at Forest, he worked at Upjohn Laboratories as director of psychopharmacology and later chief medical officer and vice president of clinical development.
Jones received an MD from Harvard Medical School, Isis said.